Consensus Afya Limited Sao Paulo

Stocks

A2FY34

BRA2FYBDR000

School, College & University

Market Closed - Sao Paulo 01:18:15 18/09/26 am AEST			5-day change	1st Jan Change
35.30 ^BRL	-0.28%		+2.14%	-14.22%

25/08	LatAm markets mixed as investors assess U.S. sanctions on Iran, Mexico data	RE
25/08	LatAm markets mixed as U.S. sanctions on Iran loom; Mexico data in focus	RE

d1f27ceee31863e4cc5ea24f.lzibDksQoI5w7AOm5qUBAqo2Ss_abrMr3rf5Z0GYuXo.00jSPAR65_Yqp23Mp-5qdvVnJYjvJulT7_OTKRTMjRXCXchcDV743AGOZA~ed04c67e73bbfacc430236cc21480c92

Analysts' recommendations: Afya Limited

24/02	BofA Securities Downgrades Afya to Neutral From Buy, Price Target is $17	MT
14/02	Afya Shares Fall After Morgan Stanley Downgrade	MT
13/02	Morgan Stanley Downgrades Afya to Underweight From Equalweight, Adjusts Price Target to $16 From $17.50	MT
16/01	UBS Downgrades Afya to Neutral From Buy, Adjusts PT to $16 From $18	MT
09/01	UBS Trims Afya Price Target to $18 From $19, Maintains Buy Rating	MT
08/01	JPMorgan Downgrades Afya to Neutral From Overweight, Adjusts Price Target to $22 From $24.50	MT
08/09/25	UBS Upgrades Afya to Buy From Neutral, $19 Price Target	MT
08/09/25	JPMorgan Upgrades Afya to Overweight, Price Target is $24.50	MT
07/08/25	Afya Shares Rise After Morgan Stanley Upgrade	MT
06/08/25	Morgan Stanley Upgrades Afya to Equalweight From Underweight, Adjusts Price Target to $17.50 From $19	MT
29/07/25	Citigroup Upgrades Afya to Neutral From Sell, Adjusts Price Target to $14 From $16	MT
12/06/25	UBS Hikes Afya Price Target to $19.50 From $17.50, Maintains Neutral Rating	MT
11/03/25	Morgan Stanley Downgrades Afya to Underweight From Equal Weight, Cuts Price Target to $17 From $19	MT
05/02/25	Bradesco BBI Downgrades Afya to Underperform From Neutral, Adjusts Price Target to $14 From $17	MT
31/01/25	Citigroup Downgrades Afya to Sell From Neutral, Adjusts Price Target to $15 From $18	MT
18/12/24	UBS Cuts Price Target on Afya to $17.50 From $19.50, Keeps Neutral Rating	MT
30/08/24	UBS Initiates Coverage on Afya With Neutral Rating, Sets $19.50 Price Target	MT
21/06/24	Morgan Stanley Adjusts Price Target on Afya to $19 From $21, Maintains Equalweight Rating	MT
27/11/23	JPMorgan Downgrades Afya to Neutral From Overweight, Adjusts Price Target to $23 From $22	MT
23/11/22	Credit Suisse Adjusts Afya's Price Target to $18 From $19, Keeps Outperform Rating	MT
14/10/22	UBS Adjusts Afya Price Target to $18 From $21, Maintains Buy Rating	MT
08/04/22	Credit Suisse Upgrades Afya to Outperform from Neutral, Adjusts Price Target to $19 from $18	MT
08/03/22	UBS Adjusts Afya Price Target to $21 From $27, Maintains Buy Rating	MT
16/02/22	Goldman Sachs Adjusts Afya's Price Target to $19 From $29, Reiterates Buy Rating	MT
22/07/21	Afya : Morgan Stanley Downgrades Afya to Equalweight from Overweight, Adjusts Price Target to $28.50 from $32	MT

More recommendations

School, College & University (NEC)

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
GRAHAM HOLDINGS COMPANY	-	-	-12.69%
AFYA LIMITED			+25.35%
PHOENIX EDUCATION PARTNERS, INC.			+55.6%
COGNA EDUCAÇÃO S.A.			+60.56%
CHINA EDUCATION GROUP HOLDINGS LIMITED			+65.84%
YDUQS PARTICIPAÇÕES S.A.			+50.93%
CAIRO FOR INVESTMENT AND REAL ESTATE DEVELOPMENTS-CIRA EDUCATION	-	-	-
VITRU EDUCAÇÃO S.A.			+32.95%
Average			+39.79%
Weighted average by Cap.			+16.94%